Published in Vaccine Weekly, February 14th, 2001
"This study analyzed a naturally-occurring specific cellular immunity against tumor cells in chronic lymphocytic leukemia (CLL) patients," stated M.R. Rezvany and colleagues, Karolinska Hospital. "Five out of eight patients had blood T lymphocytes able to recognize spontaneously and specifically the autologous tumor B cells (proliferation assay)."
Rezvany et al. published the results of their study in the British Journal of Hematology ("Autologous T...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.